BridgeMD
Compares treatment options for Type 2 Diabetes Patients
Official title Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
ClinicalTrials.gov ID: NCT03087032
What this study is testing
What is Liraglutide?
Liraglutide is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for type 2 diabetes patients.
Also referred to as Victozaa, Liraglutid.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The present 24-week, prospective, open-label, randomized, multicenter, parallel group trial is carried to investigate and evaluate the efficacy and safety of Liraglutide in combination with prandial insulin therapy vs insulin glargine in combination with prandial insulin therapy in overweight / obese patients with uncontrolled type 2 diabetes.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age: 18 - 75 years old.
- BMI must be greater than 24 and less than 45 kg/m2
- Patients with type 2 diabetes who met the World Health Organization (who) diagnostic criteria (1999).
- Newly diagnosed type 2 diabetic patients with HbA1c ≥ 9.0%；or patients with uncontrolled type 2 diabetes (HbA1c ≥ 7.5% ) who have received at least...
- Signed informed consent.
You likely can't join if
- History of pancreatic disease,
- History of medullary thyroid carcinoma
- Lipase level \> 3 times above normal,
- Creatinine clearance ≤ 30 mL/min/1.73m2,
- Evidence in the last 6 months of significant heart disease or stroke, including myocardial infarction, unstable angina, coronary bypass and/or...
- Preparation for pregnancy or having been in pregnancy
See the full eligibility criteria
- Age: 18 - 75 years old.
- BMI must be greater than 24 and less than 45 kg/m2
- Patients with type 2 diabetes who met the World Health Organization (who) diagnostic criteria (1999).
- Newly diagnosed type 2 diabetic patients with HbA1c ≥ 9.0%；or patients with uncontrolled type 2 diabetes (HbA1c ≥ 7.5% ) who have received at least two types of oral hypoglycemic drugs (the dose of each drug needs to...
- Signed informed consent.
- History of pancreatic disease,
- History of medullary thyroid carcinoma
- Lipase level \> 3 times above normal,
- Creatinine clearance ≤ 30 mL/min/1.73m2,
- Evidence in the last 6 months of significant heart disease or stroke, including myocardial infarction, unstable angina, coronary bypass and/or percutaneous transluminal coronary angioplasty, congestive heart failure...
- Preparation for pregnancy or having been in pregnancy
- Researchers believe that there are any factors that affect assessing people' participation in trial.
- Patients unable to cooperate in clinical trials
The study team makes the final eligibility decision.
Where it's taking place
- Xiamen, Fujian, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xiamen, Fujian, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.